Last reviewed · How we verify

NCT06992271

Comparing Two Eccentric Protocols on Muscle Damage

Recruiting now NA Last updated 28 May 2025
What this trial tests

NA trial testing Fast Eccentric in Eccentric Hypertrophy in 16 participants. Currently enrolling.

Timeline
8 March 2023
Primary endpoint
1 June 2025
1 June 2025

Quick facts

Lead sponsorNew York Institute of Technology
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment16
Start date8 March 2023
Primary completion1 June 2025
Estimated completion1 June 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

New York Institute of Technology

Who can join

Adults 18 to 35, any sex, with Eccentric Hypertrophy or Muscle Damage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study will be to test whether a new way of weight training is more effective than typical weight training. The investigators expect that this new way will cause more exercise-induced muscle damage, which helps people build bigger muscles. Another purpose of this study will be to explore perceptions of how muscle soreness impacts participant activities of daily living.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other New York Institute of Technology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06992271.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing